Deliargyris Efthymios — SEC Form 4 filings

SEC reporting owner CIK 1751617. 5 Form 4 filings on record with FilingPulse; latest filed 2025-08-08.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-04-02 to 2025-08-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cytosorbents Corp (CTSO)Chief Medical Officer511

Form 4 filings — Deliargyris Efthymios

FiledFormIssuerReported transactionsSource
2025-08-084Cytosorbents Corp (CTSO)Grant/award (A): 70,000 @ $0 · Grant/award (A): 95,000 (derivative) @ $0EDGAR
2025-01-224Cytosorbents Corp (CTSO)Option exercise/expiry (X): 16,233 @ $1 · Option exercise/expiry (X): 16,233 (derivative) @ $0 · Other (J): 16,233 (derivative) · Other (J): 16,233 (derivative)EDGAR
2024-10-084Cytosorbents Corp (CTSO)Grant/award (A): 100,000 (derivative) · Grant/award (A): 50,000 (derivative)EDGAR
2024-04-044Cytosorbents Corp (CTSO)Grant/award (A): 61,000 @ $0 · Grant/award (A): 86,000 (derivative)EDGAR
2024-04-024Cytosorbents Corp (CTSO)Grant/award (A): 47,088 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1751617 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →